Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

May 01, 2003; Volume 63,Issue 5

Perspective

  • You have access
    An Array of Details on G-Protein Coupled Receptor Signaling: Differential Effects of α1-Adrenergic Receptor Subtypes on Gene Expression and Cytokine Receptor Signaling
    Neil M. Nathanson
    Molecular Pharmacology May 2003, 63 (5) 959-960; DOI: https://doi.org/10.1124/mol.63.5.959

Articles

  • You have access
    The Interaction of a Constitutively Active Arrestin with the Arrestin-Insensitive 5-HT2A Receptor Induces Agonist-Independent Internalization
    John A. Gray, Anushree Bhatnagar, Vsevolod V. Gurevich and Bryan L. Roth
    Molecular Pharmacology May 2003, 63 (5) 961-972; DOI: https://doi.org/10.1124/mol.63.5.961
  • You have access
    Identification of Tyrosine 189 and Asparagine 358 of the Cholecystokinin 2 Receptor in Direct Interaction with the Crucial C-Terminal Amide of Cholecystokinin by Molecular Modeling, Site-Directed Mutagenesis, and Structure/Affinity Studies
    Céline Galés, Marc Poirot, Julien Taillefer, Bernard Maigret, Jean Martinez, Luis Moroder, Chantal Escrieut, Lucien Pradayrol, Daniel Fourmy and Sandrine Silvente-Poirot
    Molecular Pharmacology May 2003, 63 (5) 973-982; DOI: https://doi.org/10.1124/mol.63.5.973
  • You have access
    Activation and Binding of Peroxisome Proliferator-Activated Receptor γ by Synthetic Cannabinoid Ajulemic Acid
    Jilin Liu, Hui Li, Sumner H. Burstein, Robert B. Zurier and J. Don Chen
    Molecular Pharmacology May 2003, 63 (5) 983-992; DOI: https://doi.org/10.1124/mol.63.5.983
  • You have access
    Spatial Approximation between a Photolabile Residue in Position 13 of Secretin and the Amino Terminus of the Secretin Receptor
    Mengwei Zang, Maoqing Dong, Delia I. Pinon, Xi-Qin Ding, Elizabeth M. Hadac, Zhijun Li, Terry P. Lybrand and Laurence J. Miller
    Molecular Pharmacology May 2003, 63 (5) 993-1001; DOI: https://doi.org/10.1124/mol.63.5.993
  • You have access
    Crucial Role of Extracellular Signal-Regulated Kinase Pathway in Reactive Oxygen Species-Mediated Endothelin-1 Gene Expression Induced by Endothelin-1 in Rat Cardiac Fibroblasts
    Cheng-Ming Cheng, Hong-Jye Hong, Ju-Chi Liu, Neng-Lang Shih, Shu-Hui Juan, Shih-Hurng Loh, Paul Chan, Jin-Jer Chen and Tzu-Hurng Cheng
    Molecular Pharmacology May 2003, 63 (5) 1002-1011; DOI: https://doi.org/10.1124/mol.63.5.1002
  • You have access
    Glucocorticoid Receptor Antagonism by Cyproterone Acetate and RU486
    Christian Honer, Kiyean Nam, Cynthia Fink, Paul Marshall, Gary Ksander, Ricardo E. Chatelain, Wendy Cornell, Ronald Steele, Robert Schweitzer and Christoph Schumacher
    Molecular Pharmacology May 2003, 63 (5) 1012-1020; DOI: https://doi.org/10.1124/mol.63.5.1012
  • You have access
    Identification of Essential Residues Involved in the Allosteric Modulation of the Human A3 Adenosine Receptor
    Zhan-Guo Gao, Soo-Kyung Kim, Ariel S. Gross, Aishe Chen, Joshua B. Blaustein and Kenneth A. Jacobson
    Molecular Pharmacology May 2003, 63 (5) 1021-1031; DOI: https://doi.org/10.1124/mol.63.5.1021
  • You have access
    Fatty Alcohol Phosphates are Subtype-Selective Agonists and Antagonists of Lysophosphatidic Acid Receptors
    Tamas Virag, Don B. Elrod, Karoly Liliom, Vineet M. Sardar, Abby L. Parrill, Kazuaki Yokoyama, Gangadhar Durgam, Wenlin Deng, Duane D. Miller and Gabor Tigyi
    Molecular Pharmacology May 2003, 63 (5) 1032-1042; DOI: https://doi.org/10.1124/mol.63.5.1032
  • You have access
    Identification of a Compound That Directly Stimulates Phospholipase C Activity
    Yoe-Sik Bae, Taehoon G. Lee, Jun Chul Park, Jung Ho Hur, Youndong Kim, Kyun Heo, Jong-Young Kwak, Pann-Ghill Suh and Sung Ho Ryu
    Molecular Pharmacology May 2003, 63 (5) 1043-1050; DOI: https://doi.org/10.1124/mol.63.5.1043
  • You have access
    Voltage-Dependent Profile of HumanEther-a-go-go-Related Gene Channel Block Is Influenced by a Single Residue in the S6 Transmembrane Domain
    Jose A. Sănchez-Chapula, Tania Ferrer, Ricardo A. Navarro-Polanco and Michael C. Sanguinetti
    Molecular Pharmacology May 2003, 63 (5) 1051-1058; DOI: https://doi.org/10.1124/mol.63.5.1051
  • You have access
    The Nicotinic Acetylcholine Receptor Subunit α5 Mediates Short-Term Effects of Nicotine in Vivo
    Ramiro Salas, Avi Orr-Urtreger, Ron S. Broide, Arthur Beaudet, Richard Paylor and Mariella De Biasi
    Molecular Pharmacology May 2003, 63 (5) 1059-1066; DOI: https://doi.org/10.1124/mol.63.5.1059
  • You have access
    Direct Interaction of Serotonin Type 3 Receptor Ligands with Recombinant and Native α9α10-Containing Nicotinic Cholinergic Receptors
    Carla V. Rothlin, Maria I. Lioudyno, Ana F. Silbering, Paola V. Plazas, Marı́a E. Gomez Casati, Eleonora Katz, Paul S. Guth and A. Belén Elgoyhen
    Molecular Pharmacology May 2003, 63 (5) 1067-1074; DOI: https://doi.org/10.1124/mol.63.5.1067
  • You have access
    Regulation of Activator Protein-1 by 8-iso-Prostaglandin E2 in a Thromboxane A2 Receptor-Dependent and -Independent Manner
    Thomas J. Weber and Lye M. Markillie
    Molecular Pharmacology May 2003, 63 (5) 1075-1081; DOI: https://doi.org/10.1124/mol.63.5.1075
  • You have access
    [3H]R214127: A Novel High-Affinity Radioligand for the mGlu1 Receptor Reveals a Common Binding Site Shared by Multiple Allosteric Antagonists
    Hilde Lavreysen, Cor Janssen, François Bischoff, Xavier Langlois, Josée E. Leysen and Anne S. J. Lesage
    Molecular Pharmacology May 2003, 63 (5) 1082-1093; DOI: https://doi.org/10.1124/mol.63.5.1082
  • You have access
    Characterization of the Transport of Nucleoside Analog Drugs by the Human Multidrug Resistance Proteins MRP4 and MRP5
    Glen Reid, Peter Wielinga, Noam Zelcer, Marcel de Haas, Liesbeth van Deemter, Jan Wijnholds, Jan Balzarini and Piet Borst
    Molecular Pharmacology May 2003, 63 (5) 1094-1103; DOI: https://doi.org/10.1124/mol.63.5.1094
  • You have access
    Genetic Profiling of α1-Adrenergic Receptor Subtypes by Oligonucleotide Microarrays: Coupling to Interleukin-6 Secretion but Differences in STAT3 Phosphorylation and gp-130
    Pedro J. Gonzalez-Cabrera, Robert J. Gaivin, June Yun, Sean A. Ross, Robert S. Papay, Dan F. McCune, Boyd R. Rorabaugh and Dianne M. Perez
    Molecular Pharmacology May 2003, 63 (5) 1104-1116; DOI: https://doi.org/10.1124/mol.63.5.1104
  • You have access
    Potent Inhibition of Human Telomerase by Nitrostyrene Derivatives
    Joo Hee Kim, Jun Hyun Kim, Gun Eui Lee, Jong Eun Lee and In Kwon Chung
    Molecular Pharmacology May 2003, 63 (5) 1117-1124; DOI: https://doi.org/10.1124/mol.63.5.1117
  • You have access
    Destabilization of Nav1.7 Sodium Channel α-Subunit mRNA by Constitutive Phosphorylation of Extracellular Signal-Regulated Kinase: Negative Regulation of Steady-State Level of Cell Surface Functional Sodium Channels in Adrenal Chromaffin Cells
    Toshihiko Yanagita, Hideyuki Kobayashi, Yasuhito Uezono, Hiroki Yokoo, Takashi Sugano, Tomokazu Saitoh, Shin-Ichi Minami, Seiji Shiraishi and Akihiko Wada
    Molecular Pharmacology May 2003, 63 (5) 1125-1136; DOI: https://doi.org/10.1124/mol.63.5.1125
  • You have access
    Characterization of Pulmonary CYP4B2, Specific Catalyst of Methyl Oxidation of 3-Methylindole
    Brian A. Carr, Swayampakula Ramakanth, Ghazi A. Dannan and Garold S. Yost
    Molecular Pharmacology May 2003, 63 (5) 1137-1147; DOI: https://doi.org/10.1124/mol.63.5.1137
  • You have access
    Role of S-Nitrosation of Cysteine Residues in Long-Lasting Inhibitory Effect of Nitric Oxide on Arterial Tone
    Jacicarlos L. Alencar, Irina Lobysheva, Michel Geffard, Mamadou Sarr, Christa Schott, Valérie B. Schini-Kerth, Françoise Nepveu, Jean-Claude Stoclet and Bernard Muller
    Molecular Pharmacology May 2003, 63 (5) 1148-1158; DOI: https://doi.org/10.1124/mol.63.5.1148
  • You have access
    Probing the Role of Linker Substituents in Bisdioxopiperazine Analogs for Activity against Wild-Type and Mutant Human Topoisomerase IIα
    Axelle Renodon-Cornière, Tina K. Sørensen, Peter B. Jensen, John L. Nitiss, Birgitte Søkilde, Maxwell Sehested and Lars H. Jensen
    Molecular Pharmacology May 2003, 63 (5) 1159-1168; DOI: https://doi.org/10.1124/mol.63.5.1159
  • You have access
    Differential Declines in Striatal Nicotinic Receptor Subtype Function after Nigrostriatal Damage in Mice
    Maryka Quik, Jocelyn D. Sum, Paul Whiteaker, Sarah E. McCallum, Michael J. Marks, John Musachio, J. Michael Mcintosh, Allan C. Collins and Sharon R. Grady
    Molecular Pharmacology May 2003, 63 (5) 1169-1179; DOI: https://doi.org/10.1124/mol.63.5.1169
  • You have access
    Transcriptional Regulation of Human CYP3A4 Basal Expression by CCAAT Enhancer-Binding Protein α and Hepatocyte Nuclear Factor-3γ
    C. Rodrı́guez-Antona, R. Bort, R. Jover, N. Tindberg, M. Ingelman-Sundberg, M. J. Gómez-Lechón and J. V. Castell
    Molecular Pharmacology May 2003, 63 (5) 1180-1189; DOI: https://doi.org/10.1124/mol.63.5.1180
  • You have access
    Release of Cellular UDP-Glucose as a Potential Extracellular Signaling Molecule
    Eduardo R. Lazarowski, Deborah A. Shea, Richard C. Boucher and T. Kendall Harden
    Molecular Pharmacology May 2003, 63 (5) 1190-1197; DOI: https://doi.org/10.1124/mol.63.5.1190

Erratum

  • You have access
    Correction to “Cytochrome P450 3A conjugation to ubiquitin in a process distinct from classical ubiquitination pathway”
    Molecular Pharmacology May 2003, 63 (5) 1198; DOI: https://doi.org/10.1124/mol.63.5.1198
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 63 (5)
Molecular Pharmacology
Vol. 63, Issue 5
1 May 2003
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Perspective
  • Articles
  • Erratum
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics